TECHPRECISION CORP Earnings Per Share Disclosure
NOTE 6 – CAPITAL STOCK and EARNINGS PER SHARE
Common Stock
We had 50,000,000 authorized shares of common stock on March 31, 2025 and 2024, respectively. There were 9,751,825 and 8,777,432 shares of common stock outstanding at March 31, 2025 and 2024, respectively.
Preferred Stock
We have 10,000,000 authorized shares of preferred stock and our board of directors has broad power to create one or more series of preferred stock and to designate the rights, preferences, privileges, and limitations of the holders of such series. There were no shares of preferred stock outstanding at March 31, 2025 and 2024.
Earnings per Share
Basic EPS is computed by dividing reported earnings available to stockholders by the weighted average shares outstanding. Diluted EPS also includes the effect of stock options that would be dilutive. The following table provides a reconciliation of the numerators and denominators reflected in the basic and diluted earnings per share computations, as required under FASB ASC 260.
| March 31, |
| March 31, | |||
2025 | 2024 | |||||
Basic and diluted EPS |
| |||||
Net loss | $ | (2,748) | $ | (7,042) | ||
Weighted average shares – basic and diluted |
| 9,459,164 |
| 8,717,160 | ||
Net loss per share | $ | (0.29) | $ | (0.81) | ||
The following table depicts all potential common stock equivalents that have an anti-dilutive effect and are excluded from the calculation of diluted EPS (i.e., those that increase income per share or decrease loss per share) for the fiscal years ended:
| March 31, 2025 |
| March 31, 2024 | |
Stock options |
| 542,500 |
| 542,500 |
Warrants |
| 711,083 |
| 25,000 |
Restricted stock |
| 10,000 |
| — |
For a number of business reasons, we may enter into contracts that are indexed to and settled in its own stock, such as warrants. Contracts that require settlement in shares are equity instruments and measured at fair value. Subsequent changes in fair value are not recognized as long as the contracts continue to be classified as equity. In connection with the sale of our common stock and warrants to purchase shares of our common stock in fiscal 2025 in a private placement, we recorded the sale of common stock and warrants as shareholder’s equity at a combined purchase price of $3.46. The portion of the proceeds received for the stock and warrant that are allocable to the warrant was accounted for as additional paid-in-capital. The allocation was based on the relative fair market values of the two securities at the time of issuance.
Historical Timeline
| Fiscal Year | Filed | |
|---|---|---|
| 2025 | Jul 30, 2025 | Showing above |
| 2024 | Sep 13, 2024 | |
| 2023 | Jun 15, 2023 | |
| 2022 | Aug 10, 2022 | |
| 2021 | Jun 10, 2021 | |
| 2020 | Jun 11, 2020 | |
| 2019 | Jun 27, 2019 | |
| 2018 | Jun 28, 2018 | |
| 2017 | Jun 29, 2017 | |
| 2016 | Jun 28, 2016 | |
About Earnings Per Share Disclosures
The earnings per share disclosure breaks down the calculation from net income to both basic and diluted EPS, revealing the full impact of a company's capital structure on per-share economics. The reconciliation between basic and diluted share counts exposes how many stock options, RSUs, convertible securities, and warrants are potentially dilutive to existing shareholders.
Key signals: a widening gap between basic and diluted shares indicates growing dilution from equity compensation or convertible instruments. Anti-dilutive securities excluded from the diluted calculation deserve attention — they represent latent dilution that will materialize if the stock price rises. Watch for the effect of share buybacks on per-share metrics: EPS growth driven primarily by repurchases rather than income growth signals weakening fundamentals. Compare year-over-year changes in the diluted share count against equity compensation expense to assess whether management is effectively managing dilution.